首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1391926

弗雷泽症候群市场：依测试类型、最终用户、地区

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2023年11月13日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

弗雷泽症候群市场规模预计将从 2023 年的 1.412 亿美元增至 2030 年的 2.005 亿美元，预测期内复合年增长率为 5.1%。

报告范围		报告详情
基准年	2022年	2023年市场规模	1.412 亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	5.10%	2030年市场规模预测	2.005 亿美元

图 1. 弗雷泽症候群的全球市场占有率（%），按地区划分，2023 年

弗雷泽症候群（FS）是一种罕见的遗传性疾病，影响肾臟和性发育。弗雷泽症候群的特征是肾臟疾病进展为末期肾功能衰竭和性腺发育不全，导致女性没有月经週期。

Prader 博士于 1964 年创造了「弗雷泽症候群」这个术语。弗雷泽症候群是由位于 11 号染色体短臂上的 WT1 基因突变引起的。该基因在胚胎发育过程中的肾臟和性腺发育中发挥重要作用。 WT1 基因突变扰乱正常的细胞过程，导致弗雷泽症候群的特征。

弗雷泽症候群的发生率估计为十万分之一的活产儿。它主要影响女性，但男性也有罕见病例报告。弗雷泽症候群的诊断是基于临床特征、基因检测和肾臟组织的组织病理学检查。

市场动态：

弗雷泽综合症市场是由多种因素驱动的。首先，由于对遗传性疾病认识的提高和先进诊断技术的可用性，弗雷泽症候群的诊断率正在增加。因此，对基因测试和筛检的需求不断增加，推动了市场成长。

其次，弗雷泽症候群的日益普及也促进了市场的扩张。对有效的肾臟替代疗法和长期管理策略的需求创造了对创新治疗方案的需求。

不过，弗雷泽症候群市场也面临一定的抑制因素。医疗保健专业人员和公众对这种罕见疾病的认识有限，可能会导致诊断不足和治疗延迟。此外，基因检测和专门治疗的高昂费用给患者及其家人带来了挑战。

儘管有这些挑战，弗雷泽症候群市场仍存在一些机会。标靶治疗药物和个人化医疗方法的开发有望改善弗雷泽综合征患者的预后。此外，研究机构、製药公司和倡导团体之间的合作可以加速更好的诊断工具和治疗方法的研究。

本研究的主要特点

本报告对全球弗雷泽症候群市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球弗雷泽综合症市场的主要企业。
该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球弗雷泽症候群市场的各种策略矩阵，促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 141.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.10%	2030 Value Projection:	US$ 200.5 Mn

Dr. Prader in 1964 coined the term Frasier syndrome. It is caused by mutations in the WT1 gene located on the short arm of chromosome 11. This gene plays a crucial role in the development of the kidneys and gonads during embryogenesis. Mutations in the WT1 gene disrupt normal cellular processes, leading to the characteristic features of Frasier syndrome.

The incidence of Frasier syndrome is estimated to be around 1 in 100,000 live births. It predominantly affects females, although rare cases have been reported in males as well. The diagnosis of Frasier syndrome is based on clinical features, genetic testing, and histopathological examination of kidney tissue.

Market Dynamics:

The market for Frasier syndrome is driven by several factors. Firstly, rising awareness about genetic disorders and the availability of advanced diagnostic techniques have led to an increased diagnosis rate of Frasier syndrome. This has resulted in a growing demand for genetic tests and screenings, driving market growth.

Secondly, the increasing prevalence of Frasier syndrome has also contributed to market expansion. The need for effective renal replacement therapies and long-term management strategies has created a demand for innovative treatment options.

However, the market for Frasier syndrome faces certain restraints as well. Limited awareness among healthcare professionals and the general public about this rare disorder can lead to underdiagnosis and delayed treatment. Moreover, the high cost of genetic testing and specialized treatments poses a challenge for patients and their families.

Despite these challenges, the market for Frasier syndrome presents several opportunities. The development of targeted therapies and personalized medicine approaches holds promise for improved outcomes in patients with Frasier syndrome. Furthermore, collaborations between research institutions, pharmaceutical companies, and advocacy groups can help drive research on better diagnostic tools and treatment modalities.

Key Features of the Study:

This report provides in-depth analysis of the global Frasier syndrome market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Frasier syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Frasier syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Frasier syndrome market

Frasier Syndrome Market Segmentation:

By Test Type
- Genetic Testing
- Ultrasound Testing
- Others
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Frasier Syndrome Market:
- Thermo Fisher Scientific
- Invitae Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Mindray Medical
- Siemens
- Canon Medical Systems Corporation
- FUJIFILM Sonosite Inc.
- ESAOTE SPA, SAMSUNGHEALTHCARE
- Empire Genomics Inc.
- BPL Medical Technologies
- Trivitron Healthcare
- Hitachi Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Frasier Syndrome, By Test Type
- Market Frasier Syndrome, By End User
- Market Frasier Syndrome, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising awareness about genetic disorders
- Restraints
Limited awareness among healthcare professionals
- Opportunities
The development of targeted therapies and personalized medicine approaches
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Frasier Syndrome Market , By Test Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ultrasound Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Frasier Syndrome Market , By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Frasier Syndrome Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mindray Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Sonosite Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ESAOTE SPA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SAMSUNGHEALTHCARE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Empire Genomics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BPL Medical Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Trivitron Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

弗雷泽症候群市场：依测试类型、最终用户、地区

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

市场动态：

本研究的主要特点

目录

第一章研究目的与前提

第二章市场展望

第三章市场动态、法规及趋势分析

第四章弗雷泽症候群市场－冠状病毒（COVID-19）大流行的影响

第五章弗雷泽症候群市场，依测试类型，2018-2030

第 6 章弗雷泽症候群市场，按最终用户划分，2018-2030 年

第 7 章弗雷泽症候群市场，按地区，2018-2030

第八章竞争形势

第9章章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

5. Frasier Syndrome Market , By Test Type, 2018-2030, (US$ Mn)

6. Frasier Syndrome Market , By End User, 2018-2030, (US$ Mn)

7. Frasier Syndrome Market , By Region, 2018-2030, (US$ Mn)

8. Competitive Landscape

9. Section

弗雷泽症候群市场：依测试类型、最终用户、地区

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

市场动态：

本研究的主要特点

目录

第一章 研究目的与前提

第二章 市场展望

第三章市场动态、法规及趋势分析

第四章弗雷泽症候群市场－冠状病毒（COVID-19）大流行的影响

第五章弗雷泽症候群市场，依测试类型，2018-2030

第 6 章 弗雷泽症候群市场，按最终用户划分，2018-2030 年

第 7 章弗雷泽症候群市场，按地区，2018-2030

第八章竞争形势

第9章 章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

5. Frasier Syndrome Market , By Test Type, 2018-2030, (US$ Mn)

6. Frasier Syndrome Market , By End User, 2018-2030, (US$ Mn)

7. Frasier Syndrome Market , By Region, 2018-2030, (US$ Mn)

8. Competitive Landscape

9. Section

第一章研究目的与前提

第二章市场展望

第 6 章弗雷泽症候群市场，按最终用户划分，2018-2030 年

第9章章节